3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Marijuana Abuse
2
Tourette Syndrome
1
Stress Disorders, Post-Traumatic
1
Sleep Initiation and Maintenance Disorders
1
Severe Acute Respiratory Syndrome
1
Seizures
1
Parkinson Disease
1
Pancreatic Cancer Non-resectable
1
Pain
1
Opioid-Related Disorders
1
Neoplasms
1
Multiple Sclerosis
1
Marijuana Use
1
Inflammatory Bowel Diseases
1
Hepatitis C
1
Glaucoma
1
Fibromyalgia
1
Epilepsy
1
Depression
1
Crohn Disease
1
Coronavirus Infections
1
Colitis, Ulcerative
1
Chronic Traumatic Encephalopathy
1
Chronic Pain
1
Carcinoma, Hepatocellular
1
COVID-19
1
Brain Injuries, Traumatic
1
Bipolar Disorder
1
Autistic Disorder
1
Anxiety Disorders
1
Interventions
Therapeutics
29
Psychiatric Rehabilitation
20
Cognitive Behavioral Therapy
12
Early Intervention, Educational
10
Psilocybin
9
Ketamine
9
Methods
8
Saline Solution
7
Yoga
6
Surveys and Questionnaires
6
Mindfulness-Based Cognitive Therapy
6
Esketamine
6
Counseling
6
Psychosocial Intervention
5
Mindfulness
5
Methylphenidate
5
Educational Status
5
Behavior Therapy
5
Acupuncture Therapy
5
Interviews as Topic
4
Exercise Therapy
4
Exercise
4
Escitalopram
4
Control Groups
4
Caregivers
4
Psychotherapy
3
Palliative Care
3
Niacin
3
Mindfulness-Based Stress Reduction
3
Melatonin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Depression
×
Medical Marijuana
×
Clear all
NCT03944447
2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2
Unknown
200,000 enrolled